Atherogenics Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Atherogenics General Information

Description

Developer of treatments and drugs for inflammatory disease intended to better treat diseases. The company leverages technology to develop novel drugs targeting diabetes and coronary heart disease, to provide clients with efficient and cost-effective drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 8995 Westside Parkway
  • Alpharetta, GA 30004
  • United States
+1 (678)
Primary Industry
Pharmaceuticals
Corporate Office
  • 8995 Westside Parkway
  • Alpharetta, GA 30004
  • United States
+1 (678)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atherogenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Admin/Reorg 07-Oct-2008 Completed Bankruptcy: Admin/Reorg
6. Convertible Debt 14-Aug-2003 Completed Generating Revenue
5. 2PO 29-Jun-2001 Completed Generating Revenue
4. IPO 09-Aug-2000 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Sep-1999 Completed Generating Revenue
2. Early Stage VC (Series B) Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-1994 Completed Generating Revenue
To view Atherogenics’s complete valuation and funding history, request access »

Atherogenics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atherogenics FAQs

  • When was Atherogenics founded?

    Atherogenics was founded in 1993.

  • Where is Atherogenics headquartered?

    Atherogenics is headquartered in Alpharetta, GA.

  • What is the size of Atherogenics?

    Atherogenics has 20 total employees.

  • What industry is Atherogenics in?

    Atherogenics’s primary industry is Pharmaceuticals.

  • Is Atherogenics a private or public company?

    Atherogenics is a Private company.

  • What is Atherogenics’s current revenue?

    The current revenue for Atherogenics is .

  • How much funding has Atherogenics raised over time?

    Atherogenics has raised $173M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process